Impact of SARS CoV-2 in Hemoglobinopathies with Immune Disfunction and Epidemiology. A Protective Mechanism from Beta Chain Hemoglobin Defects?
Mediterr J Hematol Infect Dis
.
2020 Jul 1;12(1):e2020052.
doi: 10.4084/MJHID.2020.052.
eCollection 2020.
Authors
Lorenza Torti
1
,
Laura Maffei
1
,
Francesco Sorrentino
1
,
Paolo De Fabritiis
1
,
Rossella Miceli
2
,
Elisabetta Abruzzese
1
Affiliations
1
Hemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2), Rome, Italy.
2
Ophthalmology Department S. Eugenio Hospital/CTO, Rome, Italy.
PMID:
32670530
PMCID:
PMC7340215
DOI:
10.4084/MJHID.2020.052
No abstract available
Keywords:
Epidemiology; Hemoglobinopathies; Infection; SARS-CoV-2; Thalassemia.